North Star Investment Management Corp. - ARRAY BIOPHARMA INC ownership

ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 171 filers reported holding ARRAY BIOPHARMA INC in Q4 2016. The put-call ratio across all filers is 0.59 and the average weighting 0.3%.

Quarter-by-quarter ownership
North Star Investment Management Corp. ownership history of ARRAY BIOPHARMA INC
ValueSharesWeighting
Q2 2019$4,633,000
+90.0%
100,0000.0%0.54%
+87.7%
Q1 2019$2,438,000
+71.1%
100,0000.0%0.28%
+53.2%
Q4 2018$1,425,000
-6.2%
100,0000.0%0.19%
+9.4%
Q3 2018$1,520,000
-9.4%
100,0000.0%0.17%
-12.8%
Q2 2018$1,678,000
+46.9%
100,000
+42.9%
0.20%
+43.4%
Q1 2018$1,142,000
+41.7%
70,000
+11.1%
0.14%
+38.8%
Q4 2017$806,000
+31.1%
63,000
+26.0%
0.10%
+25.6%
Q3 2017$615,000
+47.1%
50,0000.0%0.08%
+39.3%
Q2 2017$418,000
-6.5%
50,0000.0%0.06%
-9.7%
Q1 2017$447,000
+408.0%
50,000
+400.0%
0.06%
+376.9%
Q4 2016$88,00010,0000.01%
Other shareholders

There were no reported owners of ARRAY BIOPHARMA INC in Q4 2016.

NameSharesValueWeighting ↓
View complete list of ARRAY BIOPHARMA INC shareholders